Live News

Vaccines, Vol. 11, Pages 73: Evaluation of Two Adjuvant Formulations for an Inactivated Yellow Fever 17DD Vaccine Candidate in Mice

The attenuated yellow fever (YF) vaccine is one of the most successful vaccines ever developed. After a single dose admini...

Vaccines

0 0

Vaccines, Vol. 11, Pages 71: Mortality and Associated Factors in Patients with COVID-19: Cross-Sectional Study

The novel virus severe acute respiratory syndrome coronavirus 2 (SARS-COV-2) is highly virulent and causes coronavirus dis...

Vaccines

0 0

Vaccines, Vol. 11, Pages 80: Membranous Nephropathy following Full-Dose of Inactivated SARS-CoV-2 Virus Vaccination: A Case Report and Literature Review

Vaccination against the SARS-CoV-2 virus (COVID-19) has proven to be the most effective measure to prevent the spread and ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 78: Vaccinating Children against SARS-CoV-2: A Literature Review and Survey of International Experts to Assess Safety, Efficacy and Perceptions of Vaccine Use in Children

Introduction: The balance of risks and benefits of COVID-19 vaccination in children is more complex than in adults with li...

Vaccines

0 0

Vaccines, Vol. 11, Pages 75: A Multi-Centre, Randomised, Double-Blind, Placebo-Controlled Phase III Clinical Trial Evaluating the Impact of BCG Re-Vaccination on the Incidence and Severity of SARS-CoV-2 Infections among Symptomatic Healthcare Professionals during the COVID-19 Pandemic in Poland—Evaluation of Antibody Concentrations

Tuberculosis (TB) was the predominant cause of death from a single infectious agent worldwide before the severe acute resp...

Vaccines

0 0

Vaccines, Vol. 11, Pages 76: A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice

Enteroviruses, which include Coxsackieviruses, are a common cause of virus infections in humans, and multiple serotypes of...

Vaccines

0 0

Vaccines, Vol. 11, Pages 55: Macrophages as a Potential Immunotherapeutic Target in Solid Cancers

The revolution in cancer immunotherapy over the last few decades has resulted in a paradigm shift in the clinical care of ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 60: False Contraindications for Vaccinations Result in Sub-Optimal Vaccination Coverage in Quito, Ecuador: A Cross-Sectional Study

Vaccination coverage in Ecuador has decreased since 2013, falling short of the World Health Organization’s vacci...

Vaccines

0 0

Vaccines, Vol. 11, Pages 59: Advancements in Cancer Immunotherapies

Recent work has suggested involvement of the immune system in biological therapies specifically targeting tumor microenvir...

Vaccines

0 0

Vaccines, Vol. 11, Pages 61: An Immunoinformatics Approach to Design a Potent Multi-Epitope Vaccine against Asia-1 Genotype of Crimean–Congo Haemorrhagic Fever Virus Using the Structural Glycoproteins as a Target

Crimean–Congo haemorrhagic fever (CCHF), caused by Crimean–Congo haemorrhagic fever virus (CCHFV), is ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 58: Analysis of Antibody Neutralisation Activity against SARS-CoV-2 Variants and Seasonal Human Coronaviruses NL63, HKU1, and 229E Induced by Three Different COVID-19 Vaccine Platforms

Coronaviruses infections, culminating in the recent severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 70: Vaccine Hesitancy and Perceptions of the Community about Polio in High-Risk Areas of Karachi, Sindh, Pakistan

The study aimed to determine the reasons for polio vaccine hesitancy among parents of persistently missed children (PMCs) ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 63: First Case of Paraphimosis as a Severe Complication of Monkeypox

Since May 2022, the monkeypox (MPX) virus has represented an emerging issue due to outbreaks in non-endemic areas. This re...

Vaccines

0 0

Vaccines, Vol. 11, Pages 69: The Characteristics of COVID-19 Vaccine-Associated Uveitis: A Summative Systematic Review

Numerous complications following COVID-19 vaccination has been reported in the literature, with an increasing body of evid...

Vaccines

0 0

Vaccines, Vol. 11, Pages 68: Near-Complete SARS-CoV-2 Seroprevalence among Rural and Urban Kenyans despite Significant Vaccine Hesitancy and Refusal

Considering the early inequity in global COVID-19 vaccine distribution, we compared the level of population immunity to SA...

Vaccines

0 0

Vaccines, Vol. 11, Pages 65: Vaccine-Associated Rubella Caused by the RA 27/3 Strain

Vaccine-associated rubella is a very rare adverse effect after rubella vaccination; we report the characteristics of a you...

Vaccines

0 0

Vaccines, Vol. 11, Pages 66: Vaccine or Garlic–Is It a Choice? Awareness of Medical Personnel on Prevention of Influenza Infections

Background: Preventing the spread of the influenza virus is one of the primary health policy challenges of many countries ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 64: Spatial Optimization to Improve COVID-19 Vaccine Allocation

Early distribution of COVID-19 vaccines was largely driven by population size and did not account for COVID-19 prevalence ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 47: A C57BL/6 Mouse Model of SARS-CoV-2 Infection Recapitulates Age- and Sex-Based Differences in Human COVID-19 Disease and Recovery

We present a comprehensive analysis of SARS-CoV-2 infection and recovery using wild type C57BL/6 mice and a mouse-adapted ...

Vaccines

0 0

Vaccines, Vol. 11, Pages 45: Immunological Studies to Understand Hybrid/Recombinant Variants of SARS-CoV-2

The zoonotic SARS-CoV-2 virus was present before the onset of the pandemic. It undergoes evolution, adaptation, and select...

Vaccines

0 0

Vaccines, Vol. 11, Pages 50: Effectiveness of COVID-19 Vaccination with mRNA Vaccines for Patients with Cirrhosis in Hungary: Multicentre Matched Cohort Study

Patients with cirrhosis are vulnerable to hepatic decompensation events and death following COVID-19 infection. Therefore,...

Vaccines

0 0

Vaccines, Vol. 11, Pages 53: Increase in the Immune Response in Balb/c Mice after the Co-Administration of a Vector-Based COVID-19 Vaccine with Cytosine Phosphoguanine Oligodeoxynucleotide

The effects of cytosine phosphoguanine oligodeoxynucleotides (CPG ODNs) on immune response have been demonstrated for diff...

Vaccines

0 0

Vaccines, Vol. 11, Pages 49: Effectiveness of Messenger RNA Vaccines against SARS-CoV-2 Infection in Hemodialysis Patients: A Case–Control Study

Patients with end-stage kidney disease (ESKD) are at increased risk for SARS-CoV-2 infection and its complications compare...

Vaccines

0 0

Vaccines, Vol. 11, Pages 52: Cell-Based Manufacturing Technology Increases Antigenic Match of Influenza Vaccine and Results in Improved Effectiveness

To ensure that vaccination offers the best protection against an infectious disease, sequence identity between the vaccine...

Vaccines

0 0

Vaccines, Vol. 11, Pages 44: Web-Based Reporting of Post-Vaccination Symptoms for Inactivated COVID-19 Vaccines in Jordan: A Cross-Sectional Study

Background: The perception of COVID-19 vaccines as being unsafe is a major barrier to receiving the vaccine. Providing the...

Vaccines

0 0

Vaccines, Vol. 11, Pages 43: A Retrospective Study with a Commercial Vaccine against Lyme Borreliosis in Dogs Using Two Different Vaccination Schedules: Characterization of the Humoral Immune Response

Lyme borreliosis, a multisystemic disease caused by spirochetes of the genus Borrelia, is the most common tick-borne disea...

Vaccines

0 0

Vaccines, Vol. 11, Pages 42: Unglycosylated Soluble SARS-CoV-2 Receptor Binding Domain (RBD) Produced in E. coli Combined with the Army Liposomal Formulation Containing QS21 (ALFQ) Elicits Neutralizing Antibodies against Mismatched Variants

The emergence of novel potentially pandemic pathogens necessitates the rapid manufacture and deployment of effective, stab...

Vaccines

0 0

Vaccines, Vol. 11, Pages 24: Effectiveness of COVID-19 Vaccines in Adults with Diabetes Mellitus: A Systematic Review

Persons with diabetes mellitus may have an increased risk of severe illness or death from COVID-19 compared to persons wit...

Vaccines

0 0

Vaccines, Vol. 11, Pages 25: Risk of Infection and Duration of Protection after the Booster Dose of the Anti-SARS-CoV-2 Vaccine BNT162b2 among Healthcare Workers in a Large Teaching Hospital in Italy: Results of an Observational Study

The efficacy of the first schedule of COVID-19 mRNA vaccines has decreased after the surge of the Delta variant, posing th...

Vaccines

0 0

Vaccines, Vol. 11, Pages 27: Determination of Conformational and Functional Stability of Potential Plague Vaccine Candidate in Formulation

Generally, protein-based vaccines are available in liquid form and are highly susceptible to instability under elevated te...

Vaccines

0 0

Categories

Channels

Live News